A B S TRA CT The serum lipoproteins of five patients with abetalipoproteinemia (ABL) were separated by ultracentrifugation and then analyzed either intact or after delipidation. In accord with previous findings, all of the patients lacked serum particles with the characteristics of normal low-density lipoproteins (LDL) and of the LDL apoprotein as assessed by immunochemical methods. Each patient exhibited on every examination an abnormal particle, "LDL", which had the fotational properties of LDL, the polypeptide makeup of highdensity lipoproteins HDL, the spectral and morphological characteristics of neither LDL nor HDL, and a relatively low content of cholesteryl esters. The HDL were abnormal in having a marked decrease in their total plasma content, an altered proportion of the subclasses HDL2 and HDLa, and a peculiar polypeptide distribution, comprising both normal and additional components, usually not seen in normal controls. The patients also exhibited a decrease of plasma lecithin-cholesterol acyl transferase (LCAT) activity which probably accounted for the low content of cholesteryl esters in both "LDL" and HDL, and in turn for the unusual appearance of "LDL" on electron microscopy.
INTRODUCTION
It now appears to be accepted, primarily on the basis of immunological data, that the protein normally found in low-density lipoproteins (LDL),' is absent from the plasma of patients with abetalipoproteinemia (ABL) (1) (2) (3) . This defect is a key feature of ABL. Physical and chemical abnormalities in circulating high-density lipoproteins (HDL) have previously been reported but have not been completely defined (1) (2) (3) . Moreover, small quantities of lipoproteins floating in the density range of LDL have been recognized in patients with ABL and, from chemical and immunological data, considered fatrich but otherwise normal HDL (4) . Since this 3-yrstudy was undertaken, Gotto, Levy, John, and Fredrickson (5) have studied the lipoprotein apoproteins of abetalipoproteinemic plasma and recognized the absence of one of the C peptides. Moreover, Forte and Nichols (6) reported electron microscopic studies indicating that in ABL the lipoproteins floating as LDL have an abnormal morphology.
This work is a systematic analysis carried out on the major lipoprotein classes isolated from the plasma of five patients with ABL. The results obtained, besides corroborating reported findings, also provide a firm documentation for previously unrecognized biochemical abnormalities in this disease.
METHODS
Paticts studied. A total of five patients with ABL, who have been described previously, were studied: D. P., a 10-yr-old boy (7); A. M. V., a 15-yr-old girl (8) ; M. S., an 18-yr-old male (9) ; R. I., a 19-yr-old male (10) ; and G. F., also a 19-yr-old male (11) . The plasma of each patient was studied on several occasions within a 3-yrperiod.
Conditions of blood collection. Plasma from fasting subjects was obtained by plasmaphoresis with a final acid citrate dextrose (ACD) or sodium citrate solution to plasma ratio of 1: 10. No differences were noted in analytical results between samples collected in ACD or in Na citrate. After removal of remaining red cells by centrifugation in a Sorvall RC-2 Superspeed refrigerated centrifuge (Ivan Sorvall, Inc., Newtown, Conn.) with a Sorvall GSA rotor at 4,080g for 30 min at 4VC, the plasma was made 0.001 M in EDTA, pH 7. Control specimens from healthy, normal subjects underwent the same fractionation procedures as the ABL sera. In both cases, plasma was initially centrifuged (Sorvall RC-2 centrifuge SS-34 rotor, 12,000g, 15 min, 4C) to remove chylomicrons present in normal samples.
Separation of lipoproteins. Scheme 1: Under the experimental conditions used, "very low-density lipoproteins" ("VLDL" ), "LDL", HDL2 and HDL3 were sequentially floated at the top of the centrifuge tubes, with the use of a Beckman L2 65-B ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) and Spinco 30.2 and 40.3 rotors as indicated in Table I . Scheme 2: A first-step centrifugation was carried out to float all lipoproteins of d < 1.21 g/ml. The density of the medium was then progressively diluted to obtain a "VLDL + LDL" fraction as vell as HDL2 and HDL3 or whole HDL. When either scheme was followed, the top 1-ml fractions within each lipoprotein class were pooled. VLDL or LDL were subjected to two washings (30.2 rotor; 79,488g, 24 h, 16'C), and HDL2 or HDL3 to three washings (40.3 rotor; 114,480g, 24 h, 160C) to concentrate each lipoprotein species and further purify each fraction.
The isolation of very high-density lipoprotein, (VHDL1) was carried out according to the scheme presented in (12) , with the exception that, for "VLDL" and "LDL", the technique was adapted to a "miniscale" operation, in which glass-stoppered 10-ml centrifuge tubes were used. For HDL, the ethanol-ether procedure was applied, and for "VLDL" and "LDL" the chloroform-methanol method. The delipidated apoproteins were stored at 1001C until used.
Studies on the intact particles. The particles were visualized by electron microscopy with the technique of negative staining (13) . Circular dichroic measurements were made as previously described (14) . For Studies on the delipidated apoproteins. Because of the small amount of material available, the analysis of "LDL" was limited to spectral, electrophoretic, and immunological studies. Polyacrylamide gel electrophoresis in 8 M urea was performed as previously described (14) .
The apo HDL polypeptides were fractionated by Sephadex G-200 column chromatography in 8 M urea (14) and purified as described previously (16, 17 (18) , with bovine serum albumin as standard. Any turbidity that occurred was removed by brief centrifugation or extraction with diethyl ether before the absorbance was read.
Total cholesterol was determined by the method of Franey and Amador (19) , phospholipid by the method of Chen, Toribara, and Warner (20) , with the factor of 25 used to convert inorganic phosphorous to phospholipid and triglycerides by the method of Van Handel and Zilversmit (21) . Extracts of serum, prepared by the method of Folch, were separated by thin-layer chromatography in a solvent system of petroleum ether: ethyl ether: acetic acid 90:10:1, and the cholesterol ester fraction was isolated and quantified by the ferric chloride method. The fatty acids contained in the cholesterol ester, triglyceride, phospholipid, or the free fatty acids were extracted from the silica gel with chloroform: methanol 2: 1 and methylated with methanol in sulfuric acid (22) . They were then analyzed at 1850C in a Hewlett-Packard Research Model 7620 gas chromatograph (Hewlett-Packard Co., Palo Alto, Calif.) on a 6-ft coiled stainless steel column of i" inner diameter packed with 10% ethylene glycol succinate-methyl silicone polymer (EGSS-X) on Gas Chrom P 100/200 mesh (Applied Science Labs, Inc., State College, Pa.) with a flame ionization detector. Peak areas for each fatty acid were determined by an electronic digital integrator (Model 3370 A, Hewlett-Packard). In some instances, especially during analyses of "VLDL" and "LDL", the quantities of lipid were too small to permit ordinary analytical procedures. In such cases, it was necessary to measure the cholesterol content of "VLDL" as the trimethylsilyl derivative by gas-liquid chromatography on a column of 1% Hi-EFF-3BP on 100/120 Gas Chrom Q (Applied Science Labs) at a temperature of 200'C with coprostanol and cholestone as double internal standards.
Lecithin:cholesterol acyl transferase (LCAT) measurements. The LCAT determinations on whole plasma from three ABL patients (G. F., M. S., and A. M. V.) were carried out according to the method of Stokke and Norum (23) .
RESULTS
Studies on whole lipoproteins "LDL". In all patients studied, this fraction occurred in concentrations between 1 and 2 mg of protein/100 ml. Therefore, no analytical ultracentrifugal studies were carried out.
Electron microscopic examination of this fraction by negative staining demonstrated free-standing spherical particles (inset, Fig. 1B ) with mean particle diameter of 125±15 A (SD) (range 90-160 A). However, the majority of particles examined (Fig. 1B) exhibited an unusual packing arrangement leading to a mosaic appearance. The particle length was 102±10 A (SD) (range 85-125 A). A packing arrangement of this nature was not observed with normal LDL or normal HDL. The size of these particles differs significantly from normal LDL as assessed by t-test.
By the technique of circular dichroism (Fig. 2 ) the spectrum of "LDL" from each patient was clearly distinguishable from that of normal LDL or HDL: it had a minimum at 208 nm with a shoulder around 222 nm and a crossover point at 201 nm.
Immunologically, ABL-"LDL" showed no reactivity against normal LDL antisera, but reacted readily with antisera raised against normal HDL or its protein components, apo A-I, apo A-II, and apo C (Table III) , the reaction against anti-apo A-I being the most intense. In contrast, normal control LDL reacted against anti-LDL, but not against anti-apo A-I.
Lipid studies of "LDL" demonstrated a change in the free cholesterol-to-cholesterol ester ratio, normally 30: 70, to an average value of 41: 59 for the five patients (Table IV) . In addition, the ratio of lecithin to sphingomyelin, normally 61:29, was close to one in the patients studied. The analysis of the fatty acids in LDL could be carried out only in the cholesterol ester, lecithin, and sphingomvelin fractions of two patients. These measurements documented a decrease (more than 50% normal) of the essential fatty acids: linoleic (18: 2) and arachidonic (20: 4). The decrease was also apparent in HDL.
HDL., HDL3. According to recovery experiments after ultracentrifugal fractionation, both HDL2 and HDL3 were decreased from 50% to 80% of normal, depending upon the subject studied. The ratio of HDL2: HDL3 was approximately 3: 1 based on protein content; this is the reverse of the normal ratio. Examination by the electron microscope showed that the ABL fractions HDL2, HDL3, and HDL were similar to their normal counterparts in morphological appearance and mean diameter. ABL HDL2 had a range of particle sizes from 70 to 150 A with an average particle size of 106±20 A (SD). Circular dichroic spectra of ABL HDL, and VHDL1 were similar to their normal counterparts (Fig. 2) . This was true also for HDLs (not shown in the figure). The spectra had minima at 222 nm and 208 nm, with crossover at 202 nm, as previously described for normal HDL and its subfractions (24) .
Immunological studies (Table III) Reduction of the disulfide bond in apo A-II with dithiothreotal (DTT) resulted in the well-known shift in its electrophoretic mobility. In all of the patients studied the apo A-I and apo A-II band pattern of ABL was the same as normal. Some distinctive features were present in the ABL specimens regardless of the protein load; these included: (a) bands in the fraction I-II region' more intensely stained than normal, one of which (indicated by arrows in Figs. 3 and 4) had an apparent molecular weight of about 59,000, which changed to 45,000 upon reduction; (b) the presence of two intermediate bands between apo A-I and apo A-II with apparent molecular weights of 22,000 and 20,000, respectively, one of which was affected by reduction with either DTT or P-mercaptoethanol; and (c) absence of ' The terms I and II indicate the order of elution of these fractions from Sephadex columns (14) . one of the apo C bands, with a molecular weight of about 10,000, seen in normal controls (Fig. 3 ). An attempt was made to resolve the various bands with the assumption that the extra components seen in ABL HDL were members of distinct lipoprotein species. ABL HDL2 or HDL3 was fractionated by density gradient ultracentrifugation and compared to controls. Normal HDL2 and HDL3 exhibited a major and a minor peak. By polyacrylamide gel electrophoresis in SDS, the major peak exhibited a band pattern similar to that of whole HDL2 or HDL3 (not shown in Fig. 5 ), whereas the minor peak contained essentially only apo A-I. The ABL specimens had a distinctive profile characterized by a major broad component comprising a shoulder and a peak. By polyacrylamide gel electrophoresis (see Fig.  5 ) both shoulder and peak contained apo A-I, apo A-II, Lipid studies. The protein: lipid ratios in "LDL", HDL2, and HDL3 were within the ranges reported for the corresponding classes in normal human sera. The whole HDL exhibited a significant decrease in the content of cholesteryl esters (Table V) Similar differences were also noted in HDL2 and HDLI (Table V) . Fatty acid analysis of HDL lipid classes showed a decrease in the percentage of the two essential fatty acids of 18: 2 and 20: 4. The change in linoleic acid was most evident in the cholesterol ester fraction, whereas the change in arachidonic acid was in the sphingomyelin fraction.
In the case of VHDL1 there were no significant differences in the protein: lipid ratios between normal and ABL patients, and the result were in general agreement with those reported by Alaupovic, Sanbar, Furman, Sullivan, and Wolraven (25) .
Studies with LCAT. In ABL plasma from patients A.M.V. and M. S., the activity of LCAT was reduced to 2.1% and 0.96%, respectively, compared to the normal range of 3-5% (Table VI) . A reduction in activity was also noted in patient G.F. Addition of heat-inactivated HDL from a normal subject to ABL plasma resulted in the doubling of the amount of free cholesterol esterified. When HDL derived from a patient with LCAT deficiency was added to the incubation mixture, the stimulation of enzyme activity resulted in esterification of 16 and 7 sag of free cholesterol, respectively (patients A. M. V. and M. S.). Further, the addition of whole plasma from LCAT-deficient patients to plasma (Fig. 3) . By 7.5% polyacrylamide gel electrophoresis in 8 M urea, the additional difference between normal and ABL apo HDL (Fig. 6) was the absence in the latter of one of the apo C bands, namely apo C-III-I.
Chemical studies. Two methods, Sephadex G-200 chromatography in 8 M urea and DEAE ion-exchange chromatography in 6 M urea, were used to fractionate apo HDL and apo HDL2. By Sephadex G-200 chromatography, the elution profile of ABL-apo HDL differed from normal (Fig. 7) in having comparatively larger peaks I and II and by the presence of a shoulder in an and apo A-II had the same amino acid composition as their normal counterparts (Table VIII) .
To define the abnormality in the apo C polypeptides observed by polyacrylamide-8 M urea gel electrophoresis of ABL-HDL (see Fig. 6 ) we subjected apo HDL from either normal or ABL patients to neuraminidase cleavage and then analyzed it by polyacrylamide gel electrophoresis in 8 M urea. In both instances, the two fastest migrating bands disappeared; this is compatible with the conversion of apo C-III-I and apo C-III-2, containing 1 and 2 mol of sialic acid, respectively, into apo C-III-0, the peptide without sialic acid (26) . Neuraminidase cleavage was also carried out on apo C peptides. Neuraminidase treatment again affected the two fastest migrating bands, suggesting that desialylation was the cause of the phenomenon. Further validation of this conclusion was provided by fractionation of the apo C peptides by ion-exchange chromatography according to the method developed in this laboratory,' followed by chemical analysis of the individual fractions.
DISCUSSION
The present study has provided additional evidence that the metabolic defect in ABL is a complex one (27) and affects all classes of plasma lipoproteins, although to varying degrees. The genetic nature of the observed lipoprotein abnormalities appears to be supported by the fact that these abnormalities were expressed equally in all of the patients studied regardless of sex, age, ethnic group, nutritional or drug regime, or disease state. We have shown, in agreement with data in literature (1, 2) , that a major defect in ABL is the absence of an im-'Lim, C. T., and A. M. Scanu. Manuscript in preparation.
munologically detectable LDL protein in the circulation. This lack of immunological reactivity either indicates that the "native" LDL protein is absent in ABL plasma or that, if present, its structure is so altered that its antigenic properties are affected. The presence of an "abnormal" LDL polypeptide in ABL has been postulated by Lees (28) , primarily on the basis of immunological studies. However, this concept is still in need of stringent experimental corroboration.
Another interesting abnormality, detected in the plasma of all of our patients, was the presence of lipoprotein particles occurring in minute amounts with flotational properties of LDL. These particles, referred to as "LDL", have previously been noted by Levy, Fredrickson, and Laster (4) and were considered to represent an unusually fat-rich HDL. On the other hand, our studies have shown that these particles, although possessing the major HDL apoproteins, have, overall properties of neither normal LDL nor HDL, and that their structure has not been observed with ultracentrifugally generated products in HDL (24) . Their morphological appearance in the electron microscope was particularly intriguing. As previously noted by Forte and Nichols (6) , the appearance of these particles was rather distinct from that of normal LDL or HDL, probably as a consequence of an unusual behavior under the conditions of microscopic examination. An abnormal lipoprotein morphology has also been reported for the lipoprotein of obstructive jaundice (29, 30) and in subjects with LCAT deficiency (31) . A particular feature of these lipoproteins is a disk-shaped structure seen under electron microscopy; this has been related to their low content of cholesteryl esters, which, in turn, is considered to be secondary to a deficiency of LCAT activity. Our ABL subjects showed a deficiency in LCAT activity together with a lower than normal cholesteryl ester content "LDL". This could have caused their unusual electron microscopic appearance, according to the concept that cholesteryl esters impart structural stability to serum lipoproteins (24) . The nature of the decreased activity of the LCAT enzyme in ABL is not apparent. Cooper and Guldbrandsen (32) In all of our five subjects significant anomalies were also noted in the HDL class. These anomalies were characterized by: (a) marked reduction of the total plasma concentration of HDL, particularly affecting the HDL3 subclass, as has been noted previously by Jones and Ways (27) ; (b) a peculiar behavior of these particles when they were subjected to analytical ultracentrifugation or density gradient analysis in high salts; (c) unusual polypeptide distribution; (d) abnormality in sialylation of apo C-III and (e) abnormal lipid composition. The low plasma concentration of HDL in ABL remains unexplained but must be related to an imbalance of the mechanisms regulating their production, secretion, and degradation. It is important to stress that HDL were not only reduced in quantity, but were also qualitatively abnormal in their protein, lipid, and carbohydrate moieties. As for the protein moiety, a previous report by Gotto et al. (5) As a practical corollary to our findings, the term "abetalipoproteinemia" may no longer appropriately describe a disorder in which the abnormality within the circulating lipoproteins extends beyond the LDL class.
